藥碼
FER03
藥名
Iron Drops 50 mg/mL, 30 mL/Bot
英文商品名
滴劑 Ferrum 30 mL
中文商品名
富鐵好滴劑
螢幕名
滴劑 Ferrum 30 mL
劑型
Soln
規格
iron(III)-Hydroxide Polymaltose Complex 50 mg/mL, 30 mL/bottle
成分
藥理分類
Iron Preparations
健保碼
ATC碼
藥品圖片
外觀圖片
適應症
【藥品庫存】
藥品安全警訊 (藥品回收):本品因包裝異常(瓶蓋開啟有塑膠顆粒掉出),經廠商聯繫回收停用,請改用院內其他鐵劑 (咀嚼錠 Ferrum 100 mg) 替代。更新日期:2024/6/24。
iron-deficiency anemia
藥理
Iron Salt
藥動學
Onset of action: Hematologic response: Oral, parenteral iron salts: ~3 to 10 days
Peak effect: Reticulocytosis: 5 to 10 days; hemoglobin values increase within 2 to 4 weeks
Absorption: Iron is absorbed in the duodenum and upper jejunum; in persons with normal serum iron stores, 10% of an oral dose is absorbed, this is increased to 20% to 30% in persons with inadequate iron stores.
Food and achlorhydria will decrease absorption.
Protein binding: To serum transferrin.
Excretion: Urine, sweat, sloughing of intestinal mucosa, and menses
禁忌症
Hypersensitivity to iron salts or any component of the formulation; hemochromatosis, hemolytic anemia
懷孕分類
Maternal iron requirements increase during pregnancy. Adequate iron concentrations to the fetus can be maintained regardless of maternal iron status, except in severe cases of anemia (IOM 2001). Untreated iron deficiency and iron deficiency anemia (IDA) in a pregnant female may be associated with adverse events, including low birth weight, preterm birth, or increased perinatal mortality (ACOG 95 2008; IOM 2001; Pavord 2012).
哺乳分類
Iron is present in breast milk (IOM 2001).
Maternal iron requirements are increased in breastfeeding women (IOM 2001). Breast milk levels of iron are maintained in females with mild to moderate iron deficiency anemia (IDA), but concentrations decrease if IDA is severe (El-Farrash 2012; Kumar 2008).
It is not known if maternal use of ferrous fumarate significantly changes breast milk concentrations. The World Health Organization considers ferrous salts used for anemia to be compatible with breastfeeding (WHO 2002). All postpartum women at risk of gestational anemia (regardless of breastfeeding status) may be given oral iron with or without folic acid for 6 to 12 weeks postpartum to reduce the risk of anemia (WHO 2016c).
副作用
>10%: Gastrointestinal: Constipation, darkening of stools, nausea, stomach cramps, vomiting.
1% to 10%:
Gastrointestinal: Dental discoloration, diarrhea, heartburn
Genitourinary: Urine discoloration
<1%, postmarketing, and/or case reports: Local irritation
劑量和給藥方法
懷孕婦女:80-120 drops/kg/day (200-300mg iron)
小兒調整劑量
早產兒:1-2 drops/kg/day (2.5-5 mg iron) 嬰兒(1歲以下):10-20 drops/day (25-50 mg iron) 兒童(1-12歲):20-40 drops/day (50-100 mg iron) 兒童(12歲以上)、成人、哺乳的母親:40-120 drops/day (100-300 mg iron)
腎功能調整劑量
No dosage adjustment necessary.
肝功能調整劑量
No dosage adjustment necessary.
安定性
Store below 30℃
藥袋資訊
臨床用途
鐵劑,治療缺鐵性貧血或鐵質缺乏症
主要副作用
糞便顏色改變、便秘或腹瀉、噁心、嘔吐等
泡製方法
儲存方式
請置於 15-30℃ 乾燥處儲存
注意事項
其他說明
門診 K1 | 藥庫 外用/水E21 | <本品健保不給付>
藥品外觀
顏色
形狀
剝痕
標記1
標記2
其他
健保藥價
0
自費價
720
仿單
資料庫
健保給付規定